Condition
Cognition Function
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 4 (2)
Trial Status
Enrolling By Invitation1
Completed1
Terminated1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07776145Not ApplicableNot Yet RecruitingPrimary
Effect of Probiotic on Cognitive Function
NCT07154147Phase 4Completed
Oral vs IV Sedation for Cataract Surgery in Older Adults
NCT07074704Not ApplicableEnrolling By Invitation
tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.
NCT03784222Phase 4Terminated
Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients
Showing all 4 trials